Melbourne-based startup Lyrebird Well being has not too long ago raised $12 million in new funding from a enterprise spherical led by 5 V Capital and United Kingdom-based Octopus Ventures, with participation from Startmate.
Launched in 2023, it gives a generative AI-powered scientific documentation instrument for normal practitioners. Its AI scribe has been built-in into market-leading EMR techniques in Australia, comparable to Greatest Follow and Gentu.
WHAT IT’S FOR
In a weblog put up, Lyrebird Well being shared that it’s going to utilise its contemporary funds for world growth, beginning in the UK.
In February, the startup introduced its first UK partnership with Alder Hey Kids’s NHS Basis Belief for a phased implementation of its AI scribe.
“With this elevate, we’ll deepen our funding in product high quality, privateness, and security,” founder Kai Van Lieshout added.
MARKET SNAPSHOT
Fellow AI scribe developer, Heidi Well being, additionally based mostly in Melbourne, raked in nearly $17 million in Sequence A funding in March. The startup stated these proceeds will go to creating new capabilities of its AI scribe, comparable to pre-chart abstract creation. Heidi additionally labored with Telstra Well being to launch its scientific documentation instrument in February.
In the meantime, Lyrebird additionally not too long ago secured a partnership with King’s Hospital in Dubai and introduced the combination of its AI instrument into the pre-consultation platform of Sydney-based well being tech firm HealthShare.
In August final 12 months, outpatient departments throughout Gold Coast Well being in Queensland underwent the primary stage trial of Lyrebird’s AI scribe.
Discussion about this post